CAS RN: 134395-00-9
Atorvastatin tert-Butyl Ester
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Warehouse Lead Time Inquiry
Batchno.20250921
250mg / 1g / 5g / 25g
Confirm by inquiry
Shanghai 5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 134395-00-9
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
134395-00-9 / tert-butyl (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate
Standard CAS: 134395-00-9
Multi CAS: No
Basic Information
copy
CAS
134395-00-9 copy
Multi CAS
No copy
Molecular Formula
C37H43FN2O5 copy
Molecular Weight
614.700000 copy
Exact Mass
614.315601 copy
SMILES
CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)OC(C)(C)C)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4 copy
InChI
InChI=1S/C37H43FN2O5/c1-24(2)34-33(36(44)39-28-14-10-7-11-15-28)32(25-12-8-6-9-13-25)35(26-16-18-27(38)19-17-26)40(34)21-20-29(41)22-30(42)23-31(43)45-37(3,4)5/h6-19,24,29-30,41-42H,20-23H2,1-5H3,(H,39,44)/t29-,30-/m1/s1 copy
InChIKey
GCPKKGVOCBYRML-LOYHVIPDSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
45 copy
Aromatic heavy atom count
23 copy
Fraction Csp3
0.35 copy
Rotatable bonds
12 copy
H-bond acceptors
6 copy
H-bond donors
3 copy
Molar refractivity
175.46 copy
TPSA
100.79 copy
LogP / Solubility
WLOGP
7.57 copy
MLOGP
6.71 copy
XLogP3
6.3 copy
Consensus LogP
6.86 copy
Log S (ESOL)
-8.01 copy
Class (ESOL)
Insoluble copy
Log S (Ali)
-10.07 copy
Class (Ali)
Insoluble copy
Log S (SILICOS-IT)
-11.38 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
Low copy
BBB permeant
No copy
P-gp substrate
Yes copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-1.09 copy
Drug-likeness / Medicinal Chemistry
Lipinski
No copy
Ghose
No copy
Veber
No copy
Egan
No copy
Muegge
No copy
Bioavailability score
0.17 copy
Leadlikeness
No copy
Synthetic Accessibility
5.5 copy
Safety & Transport
copy
GHS Hazard Statements
H413 (100%): May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard] copy
Precautionary Statement Codes
P273, and P501 copy